Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hiroyuki Kato, Ph.D., M.D.

Title
Institution
Department
Address

Biography
2022
Rising Star of JSGE-UEG
2022
AACR Scholar-in-Training Award in Memory of Dr. Marta I. Rendon
2022
The 16th Japan Pancreatic Association International Best Presentation Award
2022
The Mochida Memorial Foundation for Medical and Pharmaceutical Research Scholarship
2022
Daiichi Sankyo Foundation of Life Science Scholarship
2022
The Nakatomi Foundation Scholarship
2021
Japan Gastro-PLUS Conference, Outstanding Presentation Award
2021
Japan Digestive Disease Week, Young Encouragement Award
2010
Otsubo Tetsumon Fellowship Award

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kato H, Tateishi K, Iwadate D, Yamamoto K, Fujiwara H, Nakatsuka T, Kudo Y, Hayakawa Y, Ijichi H, Otsuka M, Kishikawa T, Takahashi R, Miyabayashi K, Nakai Y, Hirata Y, Toyoda A, Morishita S, Fujishiro M. HNF1B-driven three-dimensional chromatin structure for molecular classification in pancreatic cancers. Cancer Sci. 2022 Dec 13. PMID: 36511816.
    Citations:    Fields:    
  2. Yamamoto K, Iwadate D, Kato H, Nakai Y, Tateishi K, Fujishiro M. Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment. Cancers (Basel). 2022 Sep 07; 14(18). PMID: 36139512.
    Citations: 1     
  3. Yamamoto K, Iwadate D, Kato H, Nakai Y, Tateishi K, Fujishiro M. Targeting autophagy as a therapeutic strategy against pancreatic cancer. J Gastroenterol. 2022 09; 57(9):603-618. PMID: 35727403; PMCID: PMC9392712.
    Citations: 1     Fields:    Translation:HumansCells
  4. Kato H, Tateishi K, Fujiwara H, Nakatsuka T, Yamamoto K, Kudo Y, Hayakawa Y, Nakagawa H, Tanaka Y, Ijichi H, Otsuka M, Iwadate D, Oyama H, Kanai S, Noguchi K, Suzuki T, Sato T, Hakuta R, Ishigaki K, Saito K, Saito T, Takahara N, Kishikawa T, Hamada T, Takahashi R, Miyabayashi K, Mizuno S, Kogure H, Nakai Y, Hirata Y, Toyoda A, Ichikawa K, Qu W, Morishita S, Arita J, Tanaka M, Ushiku T, Hasegawa K, Fujishiro M, Koike K. MNX1-HNF1B Axis Is Indispensable for Intraductal Papillary Mucinous Neoplasm Lineages. Gastroenterology. 2022 04; 162(4):1272-1287.e16. PMID: 34953915.
    Citations: 3     Fields:    Translation:HumansCells
  5. Nakatsuka T, Tateishi K, Kato H, Fujiwara H, Yamamoto K, Kudo Y, Nakagawa H, Tanaka Y, Ijichi H, Ikenoue T, Ishizawa T, Hasegawa K, Tachibana M, Shinkai Y, Koike K. Inhibition of histone methyltransferase G9a attenuates liver cancer initiation by sensitizing DNA-damaged hepatocytes to p53-induced apoptosis. Cell Death Dis. 2021 01 19; 12(1):99. PMID: 33468997.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  6. Kato H, Tateishi K, Fujiwara H, Ijichi H, Yamamoto K, Nakatsuka T, Kakiuchi M, Sano M, Kudo Y, Hayakawa Y, Nakagawa H, Tanaka Y, Otsuka M, Hirata Y, Tachibana M, Shinkai Y, Koike K. Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis. Cancer Genomics Proteomics. 2020 Nov-Dec; 17(6):695-705. PMID: 33099471.
    Citations: 5     Fields:    Translation:Animals
  7. Sano M, Takahashi R, Ijichi H, Ishigaki K, Yamada T, Miyabayashi K, Kimura G, Mizuno S, Kato H, Fujiwara H, Nakatsuka T, Tanaka Y, Kim J, Masugi Y, Morishita Y, Tanaka M, Ushiku T, Nakai Y, Tateishi K, Ishii Y, Isayama H, Moses HL, Koike K. Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism. Gut. 2021 09; 70(9):1713-1723. PMID: 33087490.
    Citations: 10     Fields:    Translation:HumansAnimals
  8. Fujiwara H, Takahara N, Tateishi K, Tanaka M, Kanai S, Kato H, Nakatsuka T, Yamamoto K, Kogure H, Arita J, Nakai Y, Kasuga M, Ushiku T, Hasegawa K, Koike K. 5-Aminolevulinic acid-mediated photodynamic activity in patient-derived cholangiocarcinoma organoids. Surg Oncol. 2020 Dec; 35:484-490. PMID: 33126085.
    Citations: 4     Fields:    Translation:HumansAnimals
  9. Taguchi A, Ikegami S, Tokida R, Kamimura M, Sakai N, Horiuchi H, Takahashi J, Kato H. Fragility fractures and delayed wound healing after tooth extraction in Japanese older adults. J Bone Miner Metab. 2020 May; 38(3):357-362. PMID: 31897747.
    Citations: 1     Fields:    Translation:Humans
  10. Fujiwara H, Tateishi K, Misumi K, Hayashi A, Igarashi K, Kato H, Nakatsuka T, Suzuki N, Yamamoto K, Kudo Y, Hayakawa Y, Nakagawa H, Tanaka Y, Ijichi H, Kogure H, Nakai Y, Isayama H, Hasegawa K, Fukayama M, Soga T, Koike K. Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation. Sci Rep. 2019 12 11; 9(1):18859. PMID: 31827136.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  11. Sano M, Ijichi H, Takahashi R, Miyabayashi K, Fujiwara H, Yamada T, Kato H, Nakatsuka T, Tanaka Y, Tateishi K, Morishita Y, Moses HL, Isayama H, Koike K. Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion/migration and a shift of immune-inflammatory microenvironment. Oncogenesis. 2019 Jan 18; 8(2):8. PMID: 30659170.
    Citations: 33     
  12. Fujiwara H, Tateishi K, Kato H, Nakatsuka T, Yamamoto K, Tanaka Y, Ijichi H, Takahara N, Mizuno S, Kogure H, Matsubara S, Nakai Y, Koike K. Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1. Cancer Sci. 2018 Nov; 109(11):3602-3610. PMID: 30156013.
    Citations: 10     Fields:    Translation:HumansCells
  13. Kato H, Ito Y, Tanaka E, Noguchi K, Yamamoto S, Taniguchi H, Yoshida H, Kumasaka T, Nakata R. Early Gastric Cancer Recurrence Following Curative Resection Presenting as Biliary Tract Dilatation, Pancreatic Duct Dilatation and Intestinal Wall Thickening. Intern Med. 2016; 55(7):745-50. PMID: 27041158.
    Citations:    Fields:    Translation:Humans
  14. Kato H, Yoshida H, Taniguch H, Nomura R, Sato K, Suzuki I, Nakata R. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma. World J Gastroenterol. 2015 Dec 14; 21(46):13101-12. PMID: 26673627; PMCID: PMC4674729.
    Citations: 7     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kato's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (95)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.